APA

Seferina S. C., Ramaekers B. L. T., de Boer M., Dercksen M. W., van den Berkmortel F., van Kampen R. J. W., van de Wouw A. J., Voogd A. C., Tjan Heijnen V. C. G. & Joore M. A. (2017). Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium. : Oncotarget.

Chicago

Seferina Shanly C, Ramaekers Bram L T, de Boer Maaike, Dercksen M Wouter, van den Berkmortel Franchette, van Kampen Roel J W, van de Wouw Agnès J, Voogd Adri C, Tjan Heijnen Vivianne C G and Joore Manuela A. 2017. Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium. : Oncotarget.

Harvard

Seferina S. C., Ramaekers B. L. T., de Boer M., Dercksen M. W., van den Berkmortel F., van Kampen R. J. W., van de Wouw A. J., Voogd A. C., Tjan Heijnen V. C. G. and Joore M. A. (2017). Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium. : Oncotarget.

MLA

Seferina Shanly C, Ramaekers Bram L T, de Boer Maaike, Dercksen M Wouter, van den Berkmortel Franchette, van Kampen Roel J W, van de Wouw Agnès J, Voogd Adri C, Tjan Heijnen Vivianne C G and Joore Manuela A. Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium. : Oncotarget. 2017.